Yutaka YasunagaSummaryAffiliation: Osaka National Hospital Country: Japan Publications
| Collaborators
|
Detail Information
Publications
Poorly differentiated neuroendocrine carcinoma of the seminal vesicleYutaka Yasunaga
Department of Urology, National Hospital Organization Osaka National Hospital, Osaka, Japan
Int J Urol 19:370-2. 2012..The previously biopsied bone tumor was finally diagnosed as a metastasis. A systemic chemotherapy using etoposide and cisplatin failed. The patient died of cancer one-and-a-half years later...- Importance of continuing therapy and maintaining one-month relative dose intensity in sunitinib therapy for metastatic renal cell carcinomaAtsunari Kawashima
Department of Urology, Osaka University Graduate School of Medicine, 2 2 Yamadaoka, Suita City, Osaka, 565 0871, Japan
Med Oncol 29:3298-305. 2012..Continuing therapy for more than one course and maintaining more than 60 % of 1-month relative dose intensity were very important in the prolongation of progression-free survival time regardless of the initial treatment doses... 
[Validation of 2009 TNM classification based on a prognostic analysis of 350 patients treated for renal cell carcinoma]Yutaka Yasunaga
Department of Urology, National Hospital Organization Osaka National Hospital
Nihon Hinyokika Gakkai Zasshi 103:540-7. 2012..To validate 2009 TNM classification (7th edition) of renal cell carcinoma (RCC), we reevaluated our RCC database depends on 6th and 7th TNM staging and analyzed a prognostic divergence between subgroups...- [Solitary fibrous tumor of the urinary bladder: a case report]Cong Wang
Department of Urology, National Hospital Organization Osaka National Hospital
Nihon Hinyokika Gakkai Zasshi 103:640-3. 2012..MIB-1 index indicated less than 3%, thus the tumor was diagnosed as a solitary fibrous tumor. The patient has no evidence of disease 16 months after the surgery. The current case was the first report in Japan and the twelfth worldwide... - Seminal vesicle metastasis of renal cell carcinomaKyosuke Matsuzaki
Department of Urology, National Hospital Organization Osaka Medical Center, Osaka, Japan
Urology 74:1017-8. 2009..Vesiclectomy was performed. Pathohistologic examination confirmed a metastatic renal cell carcinoma of the seminal vesicle... - One-month relative dose intensity of not less than 50% predicts favourable progression-free survival in sorafenib therapy for advanced renal cell carcinoma in Japanese patientsAtsunari Kawashima
Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan
Eur J Cancer 47:1521-6. 2011..We examined the correlation between relative dose intensity (RDI) and clinical outcome of sorafenib therapy in a multi-institutional study...